If you made any changes in Pure these will be visible here soon.

Research Output 1987 2019

Filter
Comment / Debate
2017

Diabetic kidney disease: as easy as aPC?

McFadyen, J. D. & Cooper, M. E., 21 Sep 2017, In : Blood. 130, 12, p. 1390-1391 2 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

Hypoglycaemia in patients with diabetes mellitus and renal impairment

Hettige, T. S. & Cooper, M. E., 1 Mar 2017, In : Diabetes and Vascular Disease Research. 14, 2, p. 166-168 3 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

2014

Is there a diminishing return of prior glycaemic control?

Hanssen, N. M. J. & Cooper, M. E., Oct 2014, In : The Lancet Diabetes and Endocrinology. 2, 10, p. 767-769 3 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

Type 2 diabetes in Asia: Like chronic obstructive pulmonary disease, a threat to human health and wellbeing

Cooper, M. E. & Rebuck, A. S., Mar 2014, In : Journal of Diabetes. 6, 2, p. 120-122 3 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

2013

Choosing the right angiotensin-receptor blocker for patients with diabetes: Still controversial

Cooper, M. E., 3 Sep 2013, In : Canadian Medical Association Journal. 185, 12, p. 1023-1024 2 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

2012

Erratum: Methylglyoxal modification of Na v 1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy (Nature Medicine (2012) 18 (926-933))

Bierhaus, A., Fleming, T., Stoyanov, S., Leffler, A., Babes, A., Neacsu, C., Sauer, S. K., Eberhardt, M., Schnölzer, M., Lasischka, F., Neuhuber, W. L., Kichko, T. I., Konrade, I., Elvert, R., Mier, W., Pirags, V., Lukic, I. K., Morcos, M., Dehmer, T., Rabbani, N. & 13 othersThornalley, P. J., Edelstein, D., Nau, C., Forbes, J., Humpert, P. M., Schwaninger, M., Ziegler, D., Stern, D. M., Cooper, M. E., Haberkorn, U., Brownlee, M., Reeh, P. W. & Nawroth, P. P., Sep 2012, In : Nature Medicine. 18, 9, p. 1445 1 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

2011

Bardoxolone improves kidney function in type 2 diabetes

Thomas, M. C. & Cooper, M. E., Oct 2011, In : Nature Reviews Nephrology. 7, 10, p. 552-553 2 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

Erratum: ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes (Diabetes (2008) 57 (1018-1025))

Tikellis, C., Bialkowski, K., Pete, J., Sheehy, K., Su, Q., Johnston, C., Cooper, M. E. & Thomas, M. C., Jan 2011, In : Diabetes. 60, 1, p. 360 1 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

Erratum to: Increased serum potassium affects renal outcomes: A post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial (Diabetologia DOI: 10.1007/s00125-010-1922-6)

Miao, Y., Dobre, D., Lambers Heerspink, H. J., Brenner, M. B., Cooper, M. E., Parving, H. H., Shahinfar, S., Grobbee, D. E. & de Zeeuw, D., Aug 2011, In : Diabetologia. 54, 8, p. 2209 1 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

Erratum to: Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes (Diabetologia DOI: 10.1007/s00125-011-2058-z)

Forbes, J. M., Söderlund, J., Yap, F. Y. T., Knip, M., Andrikopoulos, S., Ilonen, J., Simell, O., Veijola, R., Sourris, K. C., Coughlan, M. T., Forsblom, C., Slattery, R., Grey, S. T., Wessman, M., Yamamoto, H., Bierhaus, A., Cooper, M. E. & Groop, P. H., Jun 2011, In : Diabetologia. 54, 6, p. 1586-1587 2 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

2010

DIRECT study: A commentary

Cooper, M. E., Oct 2010, In : Diabetes and Vascular Disease Research. 7, 4, p. 319-320 2 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

Into the light? Diabetic nephropathy and vitamin D

Thomas, M. C. & Cooper, M. E., 6 Nov 2010, In : The Lancet. 376, 9752, p. 1521-1522 2 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy (Diabetes (2002) 51, (3274-3282))

Forbes, J. M., Cooper, M. E., Thallas-Bonke, V., Burns, W. C., Thomas, M. C., Brammar, G. C., Lee, F., Grant, S. L., Burrell, L. A., Jerums, G. & Osicka, T. M., Apr 2010, In : Diabetes. 59, 4, p. 1113 1 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

2009

Does intensive glycemic control for type 2 diabetes mellitus have long-term benefits for cardiovascular disease risk?

Soldatos, G. & Cooper, M. E., Mar 2009, In : Nature Reviews Endocrinology. 5, 3, p. 138-139 2 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

2008

Erratum: Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia ((2008) 205:10 (2409-2417))

El-Osta, A., Brasacchio, D., Yao, D., Pocai, A., Jones, P. L., Roeder, R. G., Cooper, M. E. & Brownlee, M., 27 Oct 2008, In : Journal of Experimental Medicine. 205, 11, p. 2683 1 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

2004

The time has come to target connective tissue growth factor in diabetic complications

Twigg, S. M. & Cooper, M. E., 1 Jan 2004, In : Diabetologia. 47, 6, p. 965-968 4 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

Open Access